Lung Cancer Excellence Forum

Leaders in the field sharing authoritative insights and institutional best practices.
Featured
In the second installment of this roundtable discussion, experts sat down with Oncology Learning Network to discuss use of liquid biopsies to detect treatment resistance in lung cancer, areas for…
View More
Claire Verschraegen, MD, comments on a phase 2 study examining the use of chemotherapy with durvalumab in patients with pleural mesothelioma.
View More
Dr Bauml discusses how he and his lung cancer patients have adapted during this unprecedented time.
View More
Helen Ross, MD, discusses the role of antiangiogenics over time in treating NSCLC.
View More
Shirish Gadgeel, MBBS, discusses updated findings from the KEYNOTE-189 clinical trial.
View More
Kristin Higgins, MD, Winship Cancer Institute, shares how the treatment of patients with lung cancer has been impacted by the COVID-19 pandemic.
View More
Helen Ross, MD, discusses the need to screen patients with NSCLC for driver mutations via NGS at diagnosis and after progression to help select first-, second-, and third-line targeted therapies.
View More
Joshua Bauml, MD, shares first-hand insight on the management of lung cancer during the COVID-19 pandemic.
View More
James L. Mulshine, MD, talks about what the future holds vis-a-vis advancements in lung cancer screening.
View More
Stay in the know.
OncNet Newsletter